SPOTLIGHT: Acomplia knockoffs made in India


A newspaper is reporting that three Indian drug companies have already begun making a knockoff of sanofi-aventis' obesity drug Acomplia. And at least one of the companies says it will launch the generic competitor in any countries where it would be allowed by law. Indian law protects only those drugs patented after 1995, and Acomplia's patent dates to 1994. Report

Suggested Articles

Bristol Myers Squibb may have bounced Jounce from its roster of inherited partners, but it’s hanging onto Anokion, a Swiss autoimmune-focused biotech.

The priority review action date sets Bristol Myers up to win approval for the bluebird-partnered anti-BCMA CAR-T therapy in late March.

The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up.